Novo Nordisk is doing better than expected as pill version lifts Wegovy sales Sweden Herald 9h Ozempic Denmark Pharma
FDA proposal could support Novo Nordisk GLP‑1 exclusivity and valuation Simply Wall St 4d FDA Tirzepatide
Novo Nordisk raises 2026 guidance after Wegovy pill drives stronger-than-expected Q1 earnings Manufacturing Chemist 3h
STAT Plus: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy field STAT 6h FDA Biotech Biology
SK bioscience's Q1 revenue up 9% on Idt growth, vaccine distribution Korea Biomedical Review 7h Sanofi Science
